Iron overload impact on P-ATPases

Annals of Hematology

Volumn 97, Issue 3, 2018, Pages 377-385

  Sousa, Leilismara ^a   Pessoa, Marco Tulio C ^a   Costa, Tamara G F ^a   Cortes, Vanessa F ^a   Santos, Herica L ^a   Barbosa, Leandro Augusto ^a  

^a FEDERAL UNIVERSITY OF SÃO JOÃO DEL REI   (Brazil)

Author keywords

Ca2+ ATPase; Fe2+ ATPase; Iron overload; Na+,K+ ATPase; Oxidative stress; P type ATPase

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ADENOSINE TRIPHOSPHATASE (CALCIUM); ADENOSINE TRIPHOSPHATASE (IRON); ADENOSINE TRIPHOSPHATASE (PHOSPHORUS); ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); IRON; UNCLASSIFIED DRUG; CALCIUM;

ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HUMAN; IRON METABOLISM; IRON OVERLOAD; NONHUMAN; PRIORITY JOURNAL; REVIEW; ANIMAL; CALCIUM SIGNALING; METABOLISM; PHYSIOLOGY; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; BIOLOGICAL TRANSPORT; CALCIUM; CALCIUM SIGNALING; CALCIUM-TRANSPORTING ATPASES; HUMANS; IRON; IRON OVERLOAD; SODIUM-POTASSIUM-EXCHANGING ATPASE;

EID: 85040066888     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-017-3222-4     Document Type: Review

References (96)

1. Beutler E (2006) Disorders of iron metabolism. In: LICHTMAN MA, BEUTLER E, SELIGSOHN U, KAUSHANSKY K, KIPPS TJ, PRCHAL JT (eds) Williams hematology, 7th edn. MacGraw-Hill, New York
2. Eid R, Arab NT, Greenwood MT (2017) Iron mediated toxicity and programmed cell death: a review and a re-examination of existing paradigms. Biochim Biophys Acta 1864(2):399–430. doi:10.1016/j.bbamcr.2016.12.002
3. Lu N, Li X, Li J, Xu W, Li H, Gao Z (2011) Nitrative and oxidative modifications of enolase are associated with iron in iron-overload rats and in vitro. J Biol Inorg Chem 16(3):481–490. doi:10.1007/s00775-010-0747-6
4. Li X, Li W, Gao Z, Li H (2016) Association of cardiac injury with iron-increased oxidative and nitrative modifications of the SERCA2a isoform of sarcoplasmic reticulum Ca2+-ATPase in diabetic rats. Biochimie 127:144–152. doi:10.1016/j.biochi.2016.05.011
5. Crichton RR, Dexter DT, Ward RJ (2011) Brain iron metabolism and its perturbation in neurological diseases. J Neural Transm (Vienna) 118(3):301–314. doi:10.1007/s00702-010-0470-z
6. Castellani RJ, Moreira PI, Perry G, Zhu X (2012) The role of iron as a mediator of oxidative stress in Alzheimer disease. Biofactors 38(2):133–138. doi:10.1002/biof.1010
7. Pretorius E, Bester J, Vermeulen N, Lipinski B, Gericke GS, Kell DB (2014) Profound morphological changes in the erythrocytes and fibrin networks of patients with hemochromatosis or with hyperferritinemia, and their normalization by iron chelators and other agents. PLoS One 9(1):e85271. doi:10.1371/journal.pone.0085271
8. Cid J, Palomera L, Díaz M, Zamora C, Solano F (2014) Clinical characteristics and management of iron overload in 631 patients with chronic transfusion dependency: results from a multicentre, observational study. Blood Transfus 12(Suppl 1):s119–s123. doi:10.2450/2013.0173-12
9. Franchini M, Targher G, Montagnana M, Lippi G (2008) Iron and thrombosis. Ann Hematol 87(3):167–173. doi:10.1007/s00277-007-0416-1
10. Franchini M, Veneri D (2005) Recent advances in hereditary hemochromatosis. Ann Hematol 84(6):347–352. doi:10.1007/s00277-005-1006-8
11. Weatherall DJ, Clegg JB (1996) Thalassemia—a global public health problem. Nat Med 2(8):847–849. doi:10.1038/nm0896-847
12. Das SK, Wang W, Zhabyeyev P, Basu R, McLean B, Fan D, Parajuli N, DesAulniers J, Patel VB, Hajjar RJ, Dyck JRB, Kassiri Z, Oudit GY (2015) Iron-overload injury and cardiomyopathy in acquired and genetic models is attenuated by resveratrol therapy. Sci Rep 5(1):18132. doi:10.1038/srep18132
13. Franchini M (2005) Recent acquisitions in the management of iron overload. Ann Hematol 84(10):640–645. doi:10.1007/s00277-005-1083-8
14. Pedersen PL, Carafoli E (1987) Ion motive ATPases. I. Ubiquity, properties, and significance to cell function. Trends Biochem Sci 12:146–150. doi:10.1016/0968-0004(87)90071-5
15. Kaplan JH (2002) Biochemistry of Na,K-ATPase. Annu Rev Biochem 71(1):511–535. doi:10.1146/annurev.biochem.71.102201.141218
16. Bublitz M, Morth JP, Nissen P (2011) P-type ATPases at a glance. J Cell Sci 124(15):2515–2519. doi:10.1242/jcs.088716
17. Apell HJ (2004) How do P-type ATPases transport ions? Bioelectrochemistry 63(1–2):149–156. doi:10.1016/j.bioelechem.2003.09.021
18. Barañano DE, Wolosker H, Bae B-I, Barrow RK, Snyder SH, Ferris CD (2000) A mammalian iron ATPase induced by iron. J Biol Chem 275(20):15166–15173. doi:10.1074/jbc.275.20.15166
19. Palmgren MG, Axelsen KB (1998) Evolution of P-type ATPases. Biochim Biophys Acta Biomembr 1365(1):37–45. doi:10.1016/S0005-2728(98)00041-3
20. Carafoli E (1991) The calcium pumping ATPase of the plasma membrane. Annu Rev Physiol 53(1):531–547. doi:10.1146/annurev.ph.53.030191.002531
21. Gurgueira SA, Meneghini R (1996) An ATP-dependent iron transport system in isolated rat liver nuclei. J Biol Chem 271(23):13616–13620. doi:10.1074/jbc.271.23.13616
22. Hollán S (1996) Membrane fluidity of blood cells. Haematologia (Budap) 27(3):109–127
23. Santos HL, Rigos CF, Ciancaglini P (2006) Kinetics behaviors of Na,K-ATPase: comparison of solubilized and DPPC:DPPE-liposome reconstituted enzyme. Comp Biochem Physiol C Toxicol Pharmacol 142(3–4):309–316. doi:10.1016/j.cbpc.2005.11.003
24. Sousa L, Garcia IJP, Costa TGF, Silva LND, Renó CO, Oliveira ES, Tilelli CQ, Santos LL, Cortes VF, Santos HL, Barbosa LA (2015) Effects of iron overload on the activity of Na,K-ATPase and lipid profile of the human erythrocyte membrane. PLoS One 10(7):e0132852. doi:10.1371/journal.pone.0132852
25. Gallagher PG (2013) Disorders of red cell volume regulation. Curr Opin Hematol 20(3):201–207. doi:10.1097/MOH.0b013e32835f6870
26. Ávila RA, Silva MASC, Peixoto JV, Kassouf-Silva I, Fogaça RTH, dos Santos L (2016) Mechanisms involved in the in vitro contractile dysfunction induced by different concentrations of ferrous iron in the rat myocardium. Toxicol in Vitro 36:38–45. doi:10.1016/j.tiv.2016.07.003
27. Hirai Y (1984) Identification of Fe2+ dependent ATPase in whole particulate suspension of the rat intestinal mucosa. Nihon Ika Daigaku Zasshi 51(2):240–252. doi:10.1272/jnms1923.51.240
28. Fessel MR, Vasconcelos EG, Gurgueira SA, Meneghini R (2007) A partially purified putative iron P type-ATPase mediates Fe3+-transport into proteoliposome. Arch Biochem Biophys 458(2):229–235. doi:10.1016/j.abb.2006.12.008
29. Takeda K, Eguchi H, Soeda S, Shirahata A, Kawamura M (2005) Fe(II)/Cu(I)-dependent P-type ATPase activity in the liver of Long-Evans cinnamon rats. Life Sci 76(19):2203–2209. doi:10.1016/j.lfs.2004.10.041
30. Poss KD, Tonegawa S (1997) Heme oxygenase 1 is required for mammalian iron reutilization. Proc Natl Acad Sci U S A 94(20):10919–10924. doi:10.1073/pnas.94.20.10919
31. Ferris CD, Jaffrey SR, Sawa A, Takahashi M, Brady SD, Barrow RK, Tysoe SA, Wolosker H, Baranano DE, Dore S, Poss KD, Snyder SH (1999) Haem oxygenase-1 prevents cell death by regulating cellular iron. Nat Cell Biol 1(3):152–157. doi:10.1038/11072
32. Crichton RR, Wilmet S, Legssyer R, Ward RJ (2002) Molecular and cellular mechanisms of iron homeostasis and toxicity in mammalian cells. J Inorg Biochem 91(1):9–18. doi:10.1016/S0162-0134(02)00461-0
33. Jozkowicz A, Was H, Dulak J (2007) Heme oxygenase-1 in tumors: is it a false friend? Antioxid Redox Signal 9(12):2099–2117. doi:10.1089/ars.2007.1659
34. Marcantoni E, Di Francesco L, Dovizio M, Bruno A, Patrignani P (2012) Novel insights into the vasoprotective role of heme oxygenase-1. Int J Hypertens 2012:127910. doi:10.1155/2012/127910
35. Snyder SH, Barañano DE (2001) Heme oxygenase: a font of multiple messengers. Neuropsychopharmacology 25(3):294–298. doi:10.1016/S0893-133X(01)00275-5
36. Vanoevelen J, Dode L, Van Baelen K, Fairclough RJ, Missiaen L, Raeymaekers L, Wuytack F (2005) The secretory pathway Ca2+/Mn2+-ATPase 2 is a Golgi-localized pump with high affinity for Ca2+ ions. J Biol Chem 280(24):22800–22808. doi:10.1074/jbc.M501026200
37. Brini M, Carafoli E (2009) Calcium pumps in health and disease. Physiol Rev 89(4):1341–1378. doi:10.1152/physrev.00032.2008
38. Bogdanova A, Makhro A, Wang J, Lipp P, Kaestner L (2013) Calcium in red blood cells-a perilous balance. Int J Mol Sci 14(5):9848–9872. doi:10.3390/ijms14059848
39. Vandecaetsbeek I, Vangheluwe P, Raeymaekers L, Wuytack F, Vanoevelen J (2011) The Ca2+ pumps of the endoplasmic reticulum and Golgi apparatus. Cold Spring Harb Perspect Biol 3(5):a004184. doi:10.1101/cshperspect.a004184
40. Zaidi A, Marden MC, Poyart C, Leclerc L (1995) Protection by lazaroids of the erythrocyte (Ca2+, Mg2+)-ATPase against iron-induced inhibition. Eur J Pharmacol 290(2):133–139. doi:10.1016/0922-4106(95)90025-X
41. Grover AK, Khan I (1992) Calcium pump isoforms: diversity, selectivity and plasticity. Review article. Cell Calcium 13(1):9–17. doi:10.1016/0143-4160(92)90025-N
42. Aulestia FJ, Alonso MT, García-Sancho J (2015) Differential calcium handling by the cis and trans regions of the Golgi apparatus. Biochem J 466(3):455–465. doi:10.1042/bj20141358
43. Van Baelen K, Dode L, Vanoevelen J, Callewaert G, De Smedt H, Missiaen L, Parys JB, Raeymaekers L, Wuytack F (2004) The Ca2+/Mn2+ pumps in the Golgi apparatus. Biochim Biophys Acta Mol Cell Res 1742(1–3):103–112. doi:10.1016/j.bbamcr.2004.08.018
44. Strehler EE, Zacharias DA (2001) Role of alternative splicing in generating isoform diversity among plasma membrane calcium pumps. Physiol Rev 81(1):21–50. doi:10.1152/physrev.2001.81.1.21
45. Toyoshima C (2009) How Ca2+-ATPase pumps ions across the sarcoplasmic reticulum membrane. Biochim Biophys Acta Mol Cell Res 1793(6):941–946. doi:10.1016/j.bbamcr.2008.10.008
46. Viner RI, Ferrington DA, Williams TD, Bigelow DJ, Schöneich C (1999) Protein modification during biological aging: selective tyrosine nitration of the SERCA2a isoform of the sarcoplasmic reticulum Ca2+-ATPase in skeletal muscle. Biochem J 340(Pt 3):657–669. doi:10.1042/bj3400657
47. Wuytack F, Raeymaekers L, Missiaen L (2002) Molecular physiology of the SERCA and SPCA pumps. Cell Calcium 32(5–6):279–305. doi:10.1016/S0143416002001847
48. Görlach A, Bertram K, Hudecova S, Krizanova O (2015) Calcium and ROS: a mutual interplay. Redox Biol 6:260–271. doi:10.1016/j.redox.2015.08.010
49. Anghileri LJ, Ortal EM, Thouvenot P (2005) Role of iron-ATP complex in lymphocyte proliferation and infiltration. Biol Trace Elem Res 108(1):69–75. doi:10.1385/bter:108:1-3:069
50. Kaplán P, Matejovičová M, Mézešová V (1997) Iron-induced inhibition of Na+, K+-ATPase and Na+/Ca2+ exchanger in synaptosomes: protection by the pyridoindole stobadine. Neurochem Res 22(12):1523–1529. doi:10.1023/a:1021918931780
51. Račay P, Qteishat AWA, ElKambergy HM, Mézešová V, Lehotský J (1998) Fe2+-induced inhibition of gerbil forebrain microsomal Ca2+-ATPase: effect of stobadine, glutathione and combination of both antioxidants. Biochim Biophys Acta Biomembr 1370(1):119–126. doi:10.1016/S0005-2736(97)00255-1
52. Almeida AM, Bertoncini CR, Borecký J, Souza-Pinto NC, Vercesi AE (2006) Mitochondrial DNA damage associated with lipid peroxidation of the mitochondrial membrane induced by Fe2+-citrate. An Acad Bras Cienc 78(3):505–514. doi:10.1590/S0001-37652006000300010
53. Moreau VH, Castilho RF, Ferreira ST, Carvalho-Alves PC (1998) Oxidative damage to sarcoplasmic reticulum Ca2+-ATPase AT submicromolar iron concentrations: evidence for metal-catalyzed oxidation. Free Radic Biol Med 25(4–5):554–560. doi:10.1016/S0891-5849(98)00084-7
54. Aggarwal NT, Makielski JC (2013) Redox control of cardiac excitability. Antioxid Redox Signal 18(4):432–468. doi:10.1089/ars.2011.4234
55. Rohn TT, Hinds TR, Vincenzi FF (1993) Inhibition of the Ca pump of intact red blood cells by t-butyl hydroperoxide: importance of glutathione peroxidase. Biochim Biophys Acta Biomembr 1153(1):67–76. doi:10.1016/0005-2736(93)90277-7
56. Reeves JP, Condrescu M, Chernaya G, Gardner JP (1994) Na+/Ca2+ antiport in the mammalian heart. J Exp Biol 196(1):375–388
57. Yu SP, Canzoniero LMT, Choi DW (2001) Ion homeostasis and apoptosis. Curr Opin Cell Biol 13(4):405–411. doi:10.1016/S0955-0674(00)00228-3
58. Yalcintepe L, Halis E (2016) Modulation of iron metabolism by iron chelation regulates intracellular calcium and increases sensitivity to doxorubicin. Bosn J Basic Med Sci 16(1):14–20. doi:10.17305/bjbms.2016.576
59. Stadtman ER, Oliver CN (1991) Metal-catalyzed oxidation of proteins. Physiological consequences. J Biol Chem 266(4):2005–2008
60. Moore RB, Bamberg AD, Wilson LC, Jenkins LD, Mankad VN (1990) Ascorbate protects against tert-butyl hydroperoxide inhibition of erythrocyte membrane Ca2+ + Mg2+-ATPase. Arch Biochem Biophys 278(2):416–424. doi:10.1016/0003-9861(90)90279-8
61. Castilho RF, Carvalho-Alves PC, Vercesi AE, Ferreira ST (1996) Oxidative damage to sarcoplasmic reticulum Ca2+-pump induced by Fe2+/H2O2/ascorbate is not mediated by lipid peroxidation or thiol oxidation and leads to protein fragmentation. Mol Cell Biochem 159(2):105–114. doi:10.1007/bf00420912
62. Vasilets LA, Schwarz W (1993) Structure-function relationships of cation binding in the Na+/K+-ATPase. Biochim Biophys Acta Rev Biomembr 1154(2):201–222. doi:10.1016/0304-4157(93)90012-D
63. +-ATPase inhibition by metal ions and complexes. Hem Ind 63:499–509
64. Omotayo TI, Akinyemi GS, Omololu PA, Ajayi BO, Akindahunsi AA, Rocha JBT, Kade IJ (2015) Possible involvement of membrane lipids peroxidation and oxidation of catalytically essential thiols of the cerebral transmembrane sodium pump as component mechanisms of iron-mediated oxidative stress-linked dysfunction of the pump’s activity. Redox Biol 4:234–241. doi:10.1016/j.redox.2014.12.015
65. Panayiotidis MI, Bortner CD, Cidlowski JA (2006) On the mechanism of ionic regulation of apoptosis: would the Na+/K+-ATPase please stand up? Acta Physiol (Oxf) 187(1–2):205–215. doi:10.1111/j.1748-1716.2006.01562.x
66. Lucchesi PA, Sweadner KJ (1991) Postnatal changes in Na,K-ATPase isoform expression in rat cardiac ventricle. Conservation of biphasic ouabain affinity. J Biol Chem 266(14):9327–9331
67. Jorgensen PL, Hakansson KO, Karlish SJ (2003) Structure and mechanism of Na,K-ATPase: functional sites and their interactions. Annu Rev Physiol 65(1):817–849. doi:10.1146/annurev.physiol.65.092101.142558
68. Garty H, Karlish SJ (2006) Role of FXYD proteins in ion transport. Annu Rev Physiol 68(1):431–459. doi:10.1146/annurev.physiol.68.040104.131852
69. Ogawa H, Toyoshima C (2002) Homology modeling of the cation binding sites of Na(+)K(+)-ATPase. Proc Natl Acad Sci U S A 99(25):15977–15982. doi:10.1073/pnas.202622299
70. Geering K (2001) The functional role of beta subunits in oligomeric P-type ATPases. J Bioenerg Biomembr 33(5):425–438. doi:10.1023/A:1010623724749
71. Suhail M (2010) Na(+), K(+)-ATPase: ubiquitous multifunctional transmembrane protein and its relevance to various pathophysiological conditions. J Clin Med Res 2(1):1–17. doi:10.4021/jocmr2010.02.263w
72. Hoffman JF, Wickrema A, Potapova O, Milanick M, Yingst DR (2002) Na pump isoforms in human erythroid progenitor cells and mature erythrocytes. Proc Natl Acad Sci U S A 99(22):14572–14577. doi:10.1073/pnas.222539999
73. Blanco G (2005) Na,K-ATPase subunit heterogeneity as a mechanism for tissue-specific ion regulation. Semin Nephrol 25(5):292–303. doi:10.1016/j.semnephrol.2005.03.004
74. Fukushima Y, Post RL (1978) Binding of divalent cation to phosphoenzyme of sodium- and potassium-transport adenosine triphosphatase. J Biol Chem 253(19):6853–6862
75. Albers RW (1967) Biochemical aspects of active transport. Annu Rev Biochem 36(1):727–756. doi:10.1146/annurev.bi.36.070167.003455
76. Horisberger J-D (2004) Recent insights into the structure and mechanism of the sodium pump. Physiology 19(6):377–387. doi:10.1152/physiol.00013.2004
77. DiGiacomo JE, Pane CR, Gwiazdowski S, Mishra OP, Delivoria-Papadopoulos M (1992) Effect of graded hypoxia on brain cell membrane injury in newborn piglets. Biol Neonate 61(1):25–32. doi:10.1159/000243527
78. Groenendaal F, Shadid M, McGowan JE, Mishra OP, van Bel F (2000) Effects of deferoxamine, a chelator of free iron, on Na+,K+-ATPase activity of cortical brain cell membrane during early reperfusion after hypoxia-ischemia in newborn lambs. Pediatr Res 48(4):560–564. doi:10.1203/00006450-200010000-00023
79. Srikanthan K, Shapiro J, Sodhi K (2016) The role of Na/K-ATPase signaling in oxidative stress related to obesity and cardiovascular disease. Molecules 21(9):1172. doi:10.3390/molecules21091172
80. Patchornik G, Goldshleger R, Karlish SJD (2000) The complex ATP–Fe(2+) serves as a specific affinity cleavage reagent in ATP-Mg(2+) sites of Na,K-ATPase: Altered ligation of Fe(2+) (Mg(2+)) ions accompanies the E(1)P→E(2)P conformational change. Proc Natl Acad Sci U S A 97(22):11954–11959. doi:10.1073/pnas.220332897
81. Goldshleger R, Karlish SJD (1997) Fe-catalyzed cleavage of the α subunit of Na/K-ATPase: evidence for conformation-sensitive interactions between cytoplasmic domains. Proc Natl Acad Sci U S A 94(18):9596–9601. doi:10.1073/pnas.94.18.9596
82. Goldshleger R, Karlish SJD (1999) The energy transduction mechanism of Na,K-ATPase studied with iron-catalyzed oxidative cleavage. J Biol Chem 274(23):16213–16221. doi:10.1074/jbc.274.23.16213
83. Karlish SJ (2003) Investigating the energy transduction mechanism of P-type ATPases with Fe2+-catalyzed oxidative cleavage. Ann N Y Acad Sci 986(1):39–49. doi:10.1111/j.1749-6632.2003.tb07137.x
84. Yufu K, Itoh T, Edamatsu R, Mori A, Hirakawa M (1993) Effect of hyperbaric oxygenation on the Na+, K(+)-ATPase and membrane fluidity of cerebrocortical membranes after experimental subarachnoid hemorrhage. Neurochem Res 18(9):1033–1039. doi:10.1007/BF00966765
85. Rezin GT, Scaini G, Gonçalves CL, Ferreira GK, Cardoso MR, Ferreira AGK, Cunha MJ, Schmitz F, Varela RB, Quevedo J, Wyse ATS, Streck EL (2014) Evaluation of Na+, K+-ATPase activity in the brain of young rats after acute administration of fenproporex. Rev Bras Psiquiatr 36(2):138–142. doi:10.1590/1516-4446-2012-0956
86. Khan N, Syed DN, Ahmad N, Mukhtar H (2013) Fisetin: a dietary antioxidant for health promotion. Antioxid Redox Signal 19(2):151–162. doi:10.1089/ars.2012.4901
87. Das J, Singh R, Sharma D (2016) Antiepileptic effect of fisetin in iron-induced experimental model of traumatic epilepsy in rats in the light of electrophysiological, biochemical, and behavioral observations. Nutr Neurosci 20(4):1–10. doi:10.1080/1028415x.2016.1183342
88. Dixon IM, Hata T, Dhalla NS (1992) Sarcolemmal Na(+)-K(+)-ATPase activity in congestive heart failure due to myocardial infarction. Am J Physiol Cell Physiol 262(3):C664–C671. doi:10.1152/ajpcell.1992.262.3.C664
89. Wasserstrom JA, Aistrup GL (2005) Digitalis: new actions for an old drug. Am J Physiol Heart Circ Physiol 289(5):H1781–H1793. doi:10.1152/ajpheart.00707.2004
90. Turi JL, Piantadosi CA, Stonehuerner JD, Ghio AJ (2008) Iron accumulation in bronchial epithelial cells is dependent on concurrent sodium transport. Biometals 21(5):571–580. doi:10.1007/s10534-008-9143-x
91. Skou JC (1998) The identification of the sodium–potassium pump (Nobel Lecture). Angew Chem Int Ed 37(17):2320–2328. doi:10.1002/(sici)1521-3773(19980918)37:172320::aid-anie23203.0.co;2-2
92. Yin W, Jiang G, Takeyasu K, Zhou X (2003) Stimulation of Na,K-ATPase by low potassium is dependent on transferrin. J Membr Biol 193(3):177–184. doi:10.1007/s00232-003-2016-x
93. Zhou X, Yin W, Doi SQ, Robinson SW, Takeyasu K, Fan X (2003) Stimulation of Na,K-ATPase by low potassium requires reactive oxygen species. Am J Physiol Cell Physiol 285(2):C319–C326. doi:10.1152/ajpcell.00536.2002
94. Brissot P, de Bels F (2006) Current approaches to the management of hemochromatosis. Hematol Am Soc Hematol Educ Program 36(1):36–41. doi:10.1182/asheducation-2006.1.36
95. RENDI R, UHR ML (1964) SODIUM, potassium-requiring adenosinetriphosphatase activity. I. Purification and properties. Biochim Biophys Acta 89:520–531
96. Pham-Huy LA, He H, Pham-Huy C (2008) Free radicals, antioxidants in disease and health. Int J Biomed Sci 4(2):89–96